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Dr Gordon A Cohen (Seattle, Wash). Dr Ungerleider, I would
like to congratulate you and your coauthors for this excellent work
and I want to thank you, actually, for doing it because I think it is
a meaningful study in that nothing has been published with con-
temporary results on repair of aortic coarctation in quite awhile,
and so I really think that this adds to the literature.
I have a series of questions. I will break them into 4 general
themes and I will address all 4 themes now, but if you need me
to repeat any of them just let me know.The Journal of Thoracic and CaFirst, how does this information influence our practice moving
forward? Should we make any changes in how we practice and
should we make any changes in how we counsel families about
the surgical risk?
Second, what is the data quality, what are the limitations of the
data, and how are the data limited by combining coarctation and
hypoplastic aortic arch into a single group? Does this confuse
the message of your study?
Third, we often think of coarctation repair as a straightforward
operation with a short hospital stay. These data demonstrated
a 25% incidence of complication for coarctation and the hypoplas-
tic aortic arch group, and even higher for the other 2 with an
overall 36% incidence of complications. Should we be adjusting
our own expectations as well as those of the families for these op-
erations? How could we use this information to reduce complica-
tion rates?
And last, I was actually surprised to see the large percentage of
patients with these diagnoses who are being operated on outside of
the neonatal period. Can you speculate as to why? Interestingly, I
went to the database at Seattle Children’s since July 2006 and
looked up our own experience, because I thought it was different
than what we actually do, and in fact found almost identical num-
bers; so can you speculate as to why that is the case?
Dr Ungerleider. Thank you, Gordon, not only for your ques-
tions but for your friendship over the years.
You first question was: How is this going to influence our prac-
tice? I do not know whether it will influence our practice or
whether it should, but it certainly should help us understand our
practice. We have a lot of data now that are collected that can
give us information that we can relate to our families or to our col-
leagues about expectations. It also shows us a little bit about how
we want to modify the database in the future to answer questions
that we just simply cannot answer here, like recurrence rates or
what happens from VSD management strategies, so we have
some limitations with what we can say with the STS database
the way it is currently constructed.
You asked about data quality—Do we confuse the issue by in-
cluding hypoplastic aortic arch patients with coarctation pa-
tients?—and I hope we did not. We spent a lot of time thinking
about this and we just did not know how to separate patients hav-
ing aortic arch repair from patients having coarctation repair, be-
cause when patients have important narrowing of the aortic arch,
some people may call that an aortic arch repair and some people
a coarctation repair, and until we insert into the STS-CHSD some
kind of anatomic or physiologic descriptor that will guide the cod-
ing of arch repair versus coarctation repair—and we would rec-
ommend that perhaps that be repair that extends proximal to the
left common carotid artery—until we have that, we really cannot
separate those patients. We would like to analyze them. I can tell
you that when we looked at hypoplastic arch repair versus coarc-
tation repair, the incidence of mortality went up by about 1% for
each group. That is, 1% mortality increase from coarctation repair
to coarctation plus VSD, another 1% increase in mortality for hy-
poplastic arch repair, and then a 1% increase when VSD repair
was added to hypoplastic arch repair, but I cannot comment on
the quality of those data because we cannot specify how patients
are assigned (by their various surgical groups) to each particular
repair type.rdiovascular Surgery c Volume 145, Number 1 157
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DYou asked about coarctation and whether it is a straightforward
operation and the incidence of complications. It can be a straight-
forward operation. As you see, only about half the patients in the
isolated group had complications. It can also be a very complex op-
eration, with a high likelihood of complication, so I think it is im-
portant to recognize that. The length of stay for isolated
coarctation was about 5 days as a median. It went up to about 11
days if there was a VSD and was about 9 days when coarctation
existed with other lesions, so it can be a complex convalescence.
Last, you asked about the incidence of neonates versus other pa-
tients. It is interesting that you went back to your database. I al-
ways say the memory is a poor database and so we may
remember that we are operating on a lot of neonates and infants,
and forget that there are other patients that are getting operated
on as well. The map is not the territory, meaning that our own in-
dividual experiences may not represent the overall totality of expe-
rience in the country, and that is a major benefit of the STS
database. I think the numbers here are pretty good and I would sug-
gest that what we are seeing is that about half the patients overall
being operated on for coarctation are neonates, that this percentage
of neonates is higher in the patients with more complex disease,
and that the incidence of complications after coarctation repair
is higher than we would initially remember. Thank you.
Dr Cohen. Thanks. One other quick comment. Thank you, by
the way, for giving me the paper in advance and allowing me to re-
view it, but one thing that was not clear to me from the paper and
even from the presentation: I am assuming that you excluded hy-
poplastic left heart syndrome from group 3. You did say that you158 The Journal of Thoracic and Cardiovascular Surgincluded single ventricles. It would be helpful, I think, both in
the manuscript and in the discussion to clarify that.
Dr Ungerleider. They were excluded. Hypoplastic left heart
syndrome is a separate disease. They get arch repairs, but they usu-
ally get something in addition.
Dr Tara Karamlou (San Francisco, Calif). Hi, Ross. Great pa-
per. I just had one quick comment and a question.
In terms of looking at complications like recurrent laryngeal
nerve injury, I think those things in this database are extremely
problematic because we do not really know the denominator. I
think we have to look at those data cautiously.
One of the things that struck me as curious was that there was
a much increased incidence of nerve injury when you had a con-
comitant VSD as opposed to other complex lesions. Do you
have a reason why you think that is the case or do you think it is
just an anomaly of the data?
Dr Ungerleider. Clearly, the incidence of recurrent laryngeal
nerve would probably be very different if it were looked for in
all patients. All patients would have to receive some form of di-
rect exam, and I think that the STS database information in this
study only represents those patients who had aphonia or aspira-
tion or a reason to be coded as recurrent laryngeal nerve injury.
We can use these kinds of data to guide our questions for the fu-
ture, and so if we really want to know more about why there
seems to be a higher incidence of recurrent laryngeal nerve injury
in certain subgroups of patients, we need to construct the data-
base to help us answer those questions in the future. Thank
you all.ery c January 2013
